PHARMACOLOGY VSIM 2023 ACTUAL EXAM
GRADE A+ WITH 100% CORRECT QUESTIONS AND
ANSWERS
Pharmacology VSim discussion questions:-
The patient’s, Junetta Cooper’s, husband brought her to the emergency department this morning at 0815 because she was experiencing
angina unrelieved by nitroglycerin. She has been evaluated in the emergency room, and she is now awaiting cardiac catheterization
tomorrow to evaluate the extent of the coronary artery disease.
Mrs. Cooper is a 75-year-old African American woman who has had primary hypertension since age 55 years. Her blood pressure has
been treated with antihypertensive drugs. She has a 1-year history of stable (exertional) angina pectoris secondary to CAD. Her pain
has been successfully controlled with the nitroglycerin patch and sublingual nitroglycerin tablets.
When she arrived to the ED, vital signs were: BP 154/90 mmHg, HR 90/min, RR 14/min, and SpO2 96%. The first set of cardiac
enzymes were negative, and she had no ECG changes indicating that she was not experiencing a myocardial infarction, but the angina
pain persisted intermittently. The provider ordered treatment with sublingual nitroglycerin, morphine, and aspirin to relieve her
immediate symptoms, and clopidogrel and fondaparinux as a safety precaution. She is not complaining of pain at this time. She took
her daily meds for hypertension at home before coming here. The provider included her home meds in the orders, as she will need to
,continue on these while she is here. Oxygen is running at 1 L/min by nasal cannula and an IV with lactated Ringer’s and 5% dextrose
is infusing at 100 mL/hr.
Mrs. Cooper’s vital signs are being continuously monitored and documented every hour, and she is due for pain and vital signs
assessment per the provider’s orders.
Answer the following questions based on the above information in the corresponding discussion post in the discussions
section.
1. Why were cardiac enzymes ordered and how many sets are usually ordered at one time? How often are the cardiac enzymes
drawn?
Biomarker tests are regularly useful in making quick findings of coronary failure, with the goal that early treatment can be
started. These incorporate the catalysts creatine phosphokinase (CPK), and creatine kinase (CK), and the proteins troponin I
(TnI), and troponin T (TnT), Low degree of these chemicals and proteins are typically found in our blood, however in the
event of heart muscle harmed when the proteins and proteins spill out of harmed heart muscle cells, and their levels in the
circulation system rise. Cardiovascular biomarkers or cardiovascular chemicals are protiens that enter the circulatory system
when there has been harm to the heart muscles, as in a coronary episode.
2. What on an EKG would indicate the patient was experiencing an MI
EKG changes of infarction ST height, Q waves, and T-wave reversal. These progressions are known as the characteristic
changes of localized necrosis and happen in drives confronting the harmed tissue.
3. How much and how often is sublingal nitroglycerin given?
Sublingual dose form tablets; - 1 tablet put under the unguent whenever there's any hint of an angina assault. 1 tablet might be utilized
at regular intervals varying for up to 15 minutes. Try not to take multiple tablets in a short time. To keep angina from exercise or
stress, utilize 1 tablet 5 to 10 minutes before the action.
Post Conference:-
, 1.How did the simulated experience of Junetta Cooper’s case make you feel?
For me, it was a little frustrating working with this patient who seemed to not respond to my education of how we need to wait 5
minutes to assess pain after medication administration by informing me of her chest pain a minute after being given nitroglycerin.
Otherwise I felt like my knowledge was where it should be for this clinical situation and I was able to pass it.
2.Tell me the actions you felt went well within this scenario.
It was a good chance for medication education which is not something I personally get to do in clinical, because most of my patients
know their medications because they take them regularly at home. With this, I felt that the actions went well within this scenario was
all the opportunities for patient education.
3.Reflecting on Junetta Cooper’s case, were there any actions you would do differently if you were to repeat this scenario? If so, how
would your patient care change?
I will focus on teaching more learning on the medication before distribution of the doses rather than in between. I would assess pain
more often than I did in the scenario.
4.Discuss the potential synergistic effect(s) of Junetta Cooper’s medication and identify the potential side effect this could cause.
It can cause hypotension to patients of taking multiple doses of nitroglycerin with hydrochlorothiazide.
5. What other interprofessional team members should be involved in Junetta Cooper’s care?
For me, Junetta should acquire her own or personal health provider such dietian and a cardiologist since it was really required in her
case that she should have close monitoring regarding her health situation.
6. Describe how you would apply the knowledge and skills that you obtained in Junetta Cooper’s case to an actual patient care
situation.
GRADE A+ WITH 100% CORRECT QUESTIONS AND
ANSWERS
Pharmacology VSim discussion questions:-
The patient’s, Junetta Cooper’s, husband brought her to the emergency department this morning at 0815 because she was experiencing
angina unrelieved by nitroglycerin. She has been evaluated in the emergency room, and she is now awaiting cardiac catheterization
tomorrow to evaluate the extent of the coronary artery disease.
Mrs. Cooper is a 75-year-old African American woman who has had primary hypertension since age 55 years. Her blood pressure has
been treated with antihypertensive drugs. She has a 1-year history of stable (exertional) angina pectoris secondary to CAD. Her pain
has been successfully controlled with the nitroglycerin patch and sublingual nitroglycerin tablets.
When she arrived to the ED, vital signs were: BP 154/90 mmHg, HR 90/min, RR 14/min, and SpO2 96%. The first set of cardiac
enzymes were negative, and she had no ECG changes indicating that she was not experiencing a myocardial infarction, but the angina
pain persisted intermittently. The provider ordered treatment with sublingual nitroglycerin, morphine, and aspirin to relieve her
immediate symptoms, and clopidogrel and fondaparinux as a safety precaution. She is not complaining of pain at this time. She took
her daily meds for hypertension at home before coming here. The provider included her home meds in the orders, as she will need to
,continue on these while she is here. Oxygen is running at 1 L/min by nasal cannula and an IV with lactated Ringer’s and 5% dextrose
is infusing at 100 mL/hr.
Mrs. Cooper’s vital signs are being continuously monitored and documented every hour, and she is due for pain and vital signs
assessment per the provider’s orders.
Answer the following questions based on the above information in the corresponding discussion post in the discussions
section.
1. Why were cardiac enzymes ordered and how many sets are usually ordered at one time? How often are the cardiac enzymes
drawn?
Biomarker tests are regularly useful in making quick findings of coronary failure, with the goal that early treatment can be
started. These incorporate the catalysts creatine phosphokinase (CPK), and creatine kinase (CK), and the proteins troponin I
(TnI), and troponin T (TnT), Low degree of these chemicals and proteins are typically found in our blood, however in the
event of heart muscle harmed when the proteins and proteins spill out of harmed heart muscle cells, and their levels in the
circulation system rise. Cardiovascular biomarkers or cardiovascular chemicals are protiens that enter the circulatory system
when there has been harm to the heart muscles, as in a coronary episode.
2. What on an EKG would indicate the patient was experiencing an MI
EKG changes of infarction ST height, Q waves, and T-wave reversal. These progressions are known as the characteristic
changes of localized necrosis and happen in drives confronting the harmed tissue.
3. How much and how often is sublingal nitroglycerin given?
Sublingual dose form tablets; - 1 tablet put under the unguent whenever there's any hint of an angina assault. 1 tablet might be utilized
at regular intervals varying for up to 15 minutes. Try not to take multiple tablets in a short time. To keep angina from exercise or
stress, utilize 1 tablet 5 to 10 minutes before the action.
Post Conference:-
, 1.How did the simulated experience of Junetta Cooper’s case make you feel?
For me, it was a little frustrating working with this patient who seemed to not respond to my education of how we need to wait 5
minutes to assess pain after medication administration by informing me of her chest pain a minute after being given nitroglycerin.
Otherwise I felt like my knowledge was where it should be for this clinical situation and I was able to pass it.
2.Tell me the actions you felt went well within this scenario.
It was a good chance for medication education which is not something I personally get to do in clinical, because most of my patients
know their medications because they take them regularly at home. With this, I felt that the actions went well within this scenario was
all the opportunities for patient education.
3.Reflecting on Junetta Cooper’s case, were there any actions you would do differently if you were to repeat this scenario? If so, how
would your patient care change?
I will focus on teaching more learning on the medication before distribution of the doses rather than in between. I would assess pain
more often than I did in the scenario.
4.Discuss the potential synergistic effect(s) of Junetta Cooper’s medication and identify the potential side effect this could cause.
It can cause hypotension to patients of taking multiple doses of nitroglycerin with hydrochlorothiazide.
5. What other interprofessional team members should be involved in Junetta Cooper’s care?
For me, Junetta should acquire her own or personal health provider such dietian and a cardiologist since it was really required in her
case that she should have close monitoring regarding her health situation.
6. Describe how you would apply the knowledge and skills that you obtained in Junetta Cooper’s case to an actual patient care
situation.
